Selectivity of Cholinesterase Inhibition: Clinical Implications for the Treatment of Alzheimer’s Disease

Author： Weinstock M.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.12, Iss.4, 1999-10, pp. : 307-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer’s Disease

By Jönsson L.  

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

Cholinesterase Inhibitors Used in the Treatment of Alzheimer’s Disease: The Relationship Between Pharmacological Effects and Clinical Efficacy

By Wilkinson D.G.  

Drugs & Aging, Vol. 21, Iss. 7, 2004-01 ,pp. : 453-478

Adis International

Access to resources Recommend Favorite

Long-Term Cholinesterase Inhibitor Treatment of Alzheimer’s Disease

By Peter Johannsen  

CNS Drugs, Vol. 18, Iss. 12, 2004-01 ,pp. : 757-768

Adis International

Access to resources Recommend Favorite

Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease

By Martinez Ana   Castro Ana  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 1, 2006-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

Cholinesterase Inhibitors in the Clinical Management of Alzheimer's Disease: Importance of Early and Persistent Treatment

By Seltzer B  

The Journal of International Medical Research, Vol. 34, Iss. 4, 2006-08 ,pp. : 339-347

Field House Publishing

Access to resources Recommend Favorite